glp-1 receptor agonist use and risk of suicide death medications get at the heart addiction: study – WashU Medicine Benefit-Risk Assessment of GLP-1 Receptor

Description

Psichas A, Glass LL, Sharp SJ, Reimann F, Gribble FM

GLP-1 Receptor Agonist Market Dynamics Market Drivers Growth in Obesity Treatment Reimbursement and Rapid Expansion of Large-scale Peptide Manufacturing Drives Market The expansion of reimbursement coverage for anti-obesity medications and the inclusion of GLP-1 receptor agonists in clinical treatment guidelines are significantly increasing patient access and prescription volumes

Biochemistry (2011) 50(37):790918

Furthermore, preliminary data suggest that these compounds might play a beneficial role in intestinal diseases [77]

The models have been used to predict pharmacokinetics in special populations, including those with hepatic or renal impairment, as well as in disease states such as type 2 diabetes and obesity